US FDA approves Abbott’s TactiFlex ablation catheter
Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's TactiFlex Ablation Catheter, Sensor Enabled, which features a flexible...
HRS 2023: Researchers hope to use AI to “revolutionise” prediction of sudden cardiac death
A novel artificial intelligence (AI) model correctly identified patients at near-term risk of sustained ventricular tachycardia (VT) who could potentially benefit from preemptive interventions...
HRS 2023: Weight loss prior to catheter ablation improves outcomes in obese AF patients
Results from a clinical trial, presented at the 2023 Heart Rhythm Society annual meeting (May 19–21, New Orleans, USA), indicate that overweight and obese...
HRS 2023: Late-breaking clinical trial results support PFA as treatment option for atrial fibrillation
New data from three late-breaking clinical trials has demonstrated the safety and efficacy of pulsed field ablation (PFA) as a viable, non-thermal treatment option...
